Pickl et al. demonstrated that formation of HER2 homodimers in 3D cultures is responsible for increased cytotoxic effects with trastuzumab in HER2 positive breast and ovarian cancer cells when compared to trastuzumab effect in 2D cultures94. The gene discussed is ERBB2; the disease is ovarian carcinoma.